Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Urology|April 10, 2014
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomyNilda Gonzalez-Roibon, Jenny J Kim, Sheila F Faraj, et al.BMC Cancer|December 4, 2017
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trialsSusan Eggly, Lauren M Hamel, Elisabeth Heath, et al.Cardiovascular Toxicology|December 10, 2014
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose StudyRichard J Kovacs, Giuliana Maldonado, Analia Azaro, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 30, 2013
A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomyStephen J Freedland, Michael Carducci, Nils Kroeger, et al.Molecular Imaging and Biology|April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Esther Mena, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 14, 2008
TGF-beta signalling-related markers in cancer patients with bone metastasisJose Baselga, Mace L Rothenberg, Josep Tabernero, et al.International Journal of Radiation Oncology, Biology, Physics|August 17, 2019
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins ExperienceMatthew P Deek, Colburn Yu, Ryan Phillips, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2007
Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neckShaoyu Zhou, Sushant Kachhap, Wenyue Sun, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2015
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancerAlison T Stopeck, Karim Fizazi, Jean-Jacques Body, et al.The New England Journal of Medicine|June 1, 2007
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinomaGary Hudes, Michael Carducci, Piotr Tomczak, et al.Pageof 8